Stock Events

Stock Events

TG Therapeutics (NKB2.MU) Q3 2026 Earnings

10AugConfirmed

Q2 2026

Next

0.1

0.17

0.24

0.31

Details

Expected EPS

0.30955644

Actual EPS

N/A

Surprise EPS

-0.31

Surprise Percent

+100%

Description

TG Therapeutics (NKB2.MU) will report earnings of for Q3 2026 on August 10, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.